"10.1371_journal.pone.0020534","plos one","2011-06-15T00:00:00Z","Andreas D Kistler; Justyna Siwy; Frank Breunig; Praveen Jeevaratnam; Alexander Scherl; William Mullen; David G Warnock; Christoph Wanner; Derralynn A Hughes; Harald Mischak; Rudolf P Wüthrich; Andreas L Serra","Division of Nephrology, University Hospital, Zürich, Switzerland; Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, Florida, United States of America; Mosaiques Diagnostics and Therapeutics AG, Hannover, Germany; Division of Nephrology, University Hospital, Würzburg, Germany; Department of Haematology, Hampstead Campus, University College Medical School, London, United Kingdom; Proteomics Core Facility, Faculty of Medicine, University of Geneva, Geneva, Switzerland; School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom","Conceived and designed the experiments: ADK DGW HM RPW ALS. Performed the experiments: JS AS WM. Analyzed the data: ADK JS HM. Contributed reagents/materials/analysis tools: ADK FB PJ CW DAH RPW ALS. Wrote the paper: ADK ALS.","ADK has received travel grants from Shire HGT and honoraria from Genzyme Inc. HM is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology. JS is an employee of Mosaiques Diagnostics. DAH has received research support, travel grants and honoraria for meetings and advisory boards from Genzyme Inc, Shire HGT and Amicus therapeutics. DGW is a consultant for Genzyme Corporation on Fabry disease, and has received research support from Genzyme Corporation and Amicus therapeutics. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","06","Andreas D Kistler","ADK",12,TRUE,5,3,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
